| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_116c851e729089df9a427027272fa290 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2086 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4409 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4409
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 |
| filingDate |
2014-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aadc2be8cc59d00139d6587a374839ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c91321b0cda079361b17505dea9c007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_18c52ce92bb1bf838005eb8298c38ec4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_67354467cd1c86e42d09bf3e9521b2ef
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1b89f7065c33446f91b997668f1b44d0 |
| publicationDate |
2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2694056-C2 |
| titleOfInvention |
Anti-tuberculosis stable pharmaceutical composition in form of dispersible tablet containing granulated isoniazid and granulated rifapentine, and method for preparing it |
| abstract |
FIELD: medicine; pharmaceuticals.SUBSTANCE: group of inventions refers to tuberculosis treatment. Oral fixed-dose pharmaceutical composition in the form of a dispersible tablet which dissolves in the liquid prior to administration includes isoniazid-containing granules and at least one intragranular excipient which contains microcrystalline cellulose, sodium starch glycolate, povidone or mixtures thereof; granules containing rifapentine and at least one intragranular excipient which contains microcrystalline cellulose, sodium ascorbate, sodium starch glycolate, hydroxypropyl cellulose, gelatized starch or mixtures thereof; and at least one extragranular excipient which contains sodium ascorbate. Also disclosed is a method for preparing an oral pharmaceutical composition.EFFECT: group of inventions provides a chemically stable oral pharmaceutical composition.10 cl, 2 tbl, 2 ex |
| priorityDate |
2013-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |